Epstein-Barr virus: the impact of scientific advances on clinical practice
H Williams, DH Crawford - Blood, 2006 - ashpublications.org
Epstein-Barr virus (EBV) is a tumorigenic herpes virus that infects and persists in B
lymphocytes in the majority of humans, generally without causing disease. However, in a …
lymphocytes in the majority of humans, generally without causing disease. However, in a …
[HTML][HTML] EBV-associated diseases: Current therapeutics and emerging technologies
EBV is a prevalent virus, infecting> 90% of the world's population. This is an oncogenic virus
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …
that causes~ 200,000 cancer-related deaths annually. It is, in addition, a significant …
Epstein-Barr virus: Biology and clinical disease
B Damania, SC Kenney, N Raab-Traub - Cell, 2022 - cell.com
Epstein-Barr virus (EBV) is a ubiquitous, oncogenic virus that is associated with a number of
different human malignancies as well as autoimmune disorders. The expression of EBV viral …
different human malignancies as well as autoimmune disorders. The expression of EBV viral …
Epstein-Barr virus–associated epithelial and mesenchymal neoplasms
AT Deyrup - Human pathology, 2008 - Elsevier
Epstein-Barr virus (EBV) is a ubiquitous human pathogen that usually maintains a
harmonious relationship with its host. Rarely, this host-virus balance is perturbed, causing a …
harmonious relationship with its host. Rarely, this host-virus balance is perturbed, causing a …
Immune escape by Epstein–Barr virus associated malignancies
C Münz, A Moormann - Seminars in cancer biology, 2008 - Elsevier
Persistent Epstein–Barr virus (EBV) infection remains asymptomatic in the majority of virus
carriers, despite the potent growth transforming potential of this virus. The increased …
carriers, despite the potent growth transforming potential of this virus. The increased …
Epstein-Barr virus: an important vaccine target for cancer prevention
JI Cohen, AS Fauci, H Varmus, GJ Nabel - Science translational …, 2011 - science.org
Participants at the February 2011 meeting at the US National Institutes of Health on Epstein-
Barr virus (EBV) vaccine research recommend that future clinical trials have two goals …
Barr virus (EBV) vaccine research recommend that future clinical trials have two goals …
Epstein–Barr virus infection and nasopharyngeal carcinoma
SW Tsao, CM Tsang, KW Lo - … Transactions of the …, 2017 - royalsocietypublishing.org
Epstein–Barr virus (EBV) is associated with multiple types of human cancer, including
lymphoid and epithelial cancers. The closest association with EBV infection is seen in …
lymphoid and epithelial cancers. The closest association with EBV infection is seen in …
Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing …
ABSTRACT Epstein-Barr virus (EBV)-encoded molecules have been detected in the tumor
tissues of several cancers, including nasopharyngeal carcinoma (NPC), suggesting that …
tissues of several cancers, including nasopharyngeal carcinoma (NPC), suggesting that …
[HTML][HTML] Integrative identification of Epstein–Barr virus–associated mutations and epigenetic alterations in gastric cancer
Background & Aims The mechanisms by which Epstein–Barr virus (EBV) contributes to the
development of gastric cancer are unclear. We investigated EBV-associated genomic and …
development of gastric cancer are unclear. We investigated EBV-associated genomic and …
[HTML][HTML] The role of Epstein–Barr virus in nasopharyngeal carcinoma
Nasopharyngeal carcinoma (NPC) is a metastasis-prone malignancy closely associated
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …
with the Epstein–Barr virus (EBV). Despite ubiquitous infection of EBV worldwide, NPC …